Skip to main content
Advertising

Originally published Friday, October 26, 2012 at 8:48 PM

  • Share:
             
  • Comments (0)
  • Print

Feds probe link between opioid injections, clots

Federal authorities say they are working with Tennessee officials to investigate why at least 12 patients in that state who injected the pain reliever Opana ER for non-medical reasons since February have a rare blood disorder.

The Associated Press

Most Popular Comments
Hide / Show comments
No comments have been posted to this article.
Start the conversation >

advertising

ATLANTA —

Federal authorities say they are working with Tennessee officials to investigate why at least 12 patients in that state who injected the pain reliever Opana ER for non-medical reasons since February have a rare blood disorder.

The Centers for Disease Control and Prevention issued the health advisory Friday night regarding the pain reliever, an extended-release form of oxymorphone. The CDC is working with the Food and Drug Administration and the Tennessee Department of Health.

The investigation is focusing on a cluster of patients with Thrombotic Thrombocytopenic Purpura, described by officials as a blood disorder in which clots form in small blood vessels throughout the body. It is an uncommon but serious illness.

Authorities say Opana ER is only supposed to be taken orally. The cases were reported in Tennessee from April 16 to Oct. 19. Most of the women did not have a prescription and reported a history of chronic IV use of the opioid pain reliever for nonmedical reasons. All of the women were hospitalized, but no deaths have occurred.

News where, when and how you want it

Email Icon

Get ready for 2015

Get ready for 2015

The Seattle Times 12-month wall calendar features hand-picked photos of life in the Pacific Northwest. Order while supplies last!

Advertising

Advertising


Advertising